Evidence map›Paper›PMID 40303234›Full record

ArticlePediatric diabetes2023

Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.

Korey K Hood, William H Polonsky, Sarah A MacLeish, Carol J Levy, Gregory P Forlenza, Amy B Criego, Bruce A Buckingham, Bruce W Bode, David W Hansen, Jennifer L Sherr and 8 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Korey K HoodDepartment of Pediatrics, Psychiatry & Behavioral Sciences, Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
William H PolonskyUniversity of California San Diego, San Diego, CA, USA.
Sarah A MacLeishUniversity Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
Carol J LevyIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Gregory P ForlenzaBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-3607-9788
Amy B CriegoInternational Diabetes Center, Health Partners Institute, Minneapolis, MN, USA.
Bruce A BuckinghamDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA.
Bruce W BodeAtlanta Diabetes Associates, Atlanta, GA, USA.
David W HansenDepartment of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA.
Jennifer L SherrDepartment of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
Sue A BrownDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
Daniel J DeSalvoDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Sanjeev N MehtaJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Anuj BhargavaDepartment of Research, Iowa Diabetes Research, West Des Moines, IA, USA.
Lauren M HuyettInsulet Corporation, Acton, MA, USA.
Todd E VienneauInsulet Corporation, Acton, MA, USA.
Trang T LyInsulet Corporation, Acton, MA, USA.ORCID 0000-0002-5995-1447

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

Objective: While automated insulin delivery (AID) systems aim to improve glycemic outcomes, the opportunity to improve psychosocial outcomes is also of critical importance for children and adolescents with type 1 diabetes and their caregivers. We evaluated psychosocial outcomes in these groups during a clinical trial of a tubeless AID system, the Omnipod® 5 Automated Insulin Delivery System. Methods: This single-arm, multicenter, prospective study enrolled 83 children (6.0-11.9 years) and 42 adolescents (12.0-17.9 years) with type 1 diabetes to use a tubeless AID system for 3 months. Participants and their caregivers completed age- and role-appropriate validated questionnaires to assess changes in psychosocial outcomes-diabetes distress (PAID), hypoglycemia confidence (HCS), well-being (WHO-5), sleep quality (PSQI), insulin delivery satisfaction (IDSS), and system usability (SUS)-before and after 3 months of AID system use. Associations between participant characteristics and glycemic outcomes with psychosocial measures were evaluated using linear regression analyses. Results: Improvements were found for children, adolescents, and/or their caregivers for diabetes-related distress, insulin delivery satisfaction, and system usability (all Conclusions: The tubeless AID system was associated with significant improvements in a number of psychosocial outcomes for children, adolescents, and their caregivers.

Indexed as

CaregiversDiabetes Mellitus, Type 1Hypoglycemic AgentsInsulinInsulin Infusion SystemsAdolescentChildFemaleHumansMaleProspective StudiesHypoglycemic AgentsInsulin

Identifiers

PMID40303234
PMCPMC12017088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.